Literature DB >> 24993773

The relationship of central foveal thickness to urinary iodine concentration in retinitis pigmentosa with or without cystoid macular edema.

Michael A Sandberg1, Elizabeth N Pearce2, Shyana Harper1, Carol Weigel-DiFranco1, Lois Hart3, Bernard Rosner1, Eliot L Berson1.   

Abstract

IMPORTANCE: Current treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP) are not always effective, may lead to adverse effects, and may not restore visual acuity. The present research lays the rationale for evaluating whether an iodine supplement could reduce CME in RP.
OBJECTIVE: To determine whether central foveal thickness (CFT) in the presence of CME is related to dietary iodine intake inferred from urinary iodine concentration (UIC) in nonsmoking adults with RP. DESIGN, SETTING, AND PARTICIPANTS: We performed a cross-sectional observational study of 212 nonsmoking patients aged 18 to 69 years referred to our institution for RP with visual acuity of no worse than 20/200 in at least 1 eye. EXPOSURE: Retinitis pigmentosa with or without CME. MAIN OUTCOMES AND MEASURES: With the eye as the unit of analysis, the relationship of log CFT measured by optical coherence tomography to UIC measured from multiple spot samples and represented as a 3-level classification variable (<100, 100-199, and ≥200 µg/L), assigning greater weight to patients with more reliable UIC estimates.
RESULTS: Analyses were limited to 199 patients after excluding 11 who failed to return urine samples for measuring UIC and 2 outliers for UIC. Of the 199 patients, 36.2% had CME in 1 or both eyes. Although log CFT was inversely related to UIC based on findings from all eyes (P = .02), regression of log CFT on UIC separately for eyes with and without CME showed a strong inverse significant relationship for the former group (P < .001) and no significant relationship for the latter group (P = .66) as tested. For the eyes with CME, CFT ranged from a geometric mean of 267 µm for a median UIC of less than 100 µg/L to a geometric mean of 172 µm for a median UIC of 200 µg/L or greater. In contrast, we found no significant association between CME prevalence and UIC based on the entire sample as tested (odds ratio, 1.01 [95% CI, 0.38-2.67]; P = .99). CONCLUSIONS AND RELEVANCE: A higher UIC in nonsmoking adults with RP was significantly associated with less central foveal swelling in eyes with CME. Additional study is required to determine whether an iodine supplement can limit or reduce the extent of CME in patients with RP.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24993773      PMCID: PMC4192011          DOI: 10.1001/jamaophthalmol.2014.1726

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  42 in total

1.  Dietary evaluation and attenuation of relative risk: multiple comparisons between blood and urinary biomarkers, food frequency, and 24-hour recall questionnaires: the DEARR study.

Authors:  Iris Shai; Bernard A Rosner; Danit R Shahar; Hilel Vardi; Ayelet B Azrad; Ayala Kanfi; Dan Schwarzfuchs; Drora Fraser
Journal:  J Nutr       Date:  2005-03       Impact factor: 4.798

2.  The association between visual acuity and central retinal thickness in retinitis pigmentosa.

Authors:  Michael A Sandberg; Robert J Brockhurst; Alexander R Gaudio; Eliot L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-09       Impact factor: 4.799

3.  The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.

Authors:  B Moldow; B Sander; M Larsen; C Engler; B Li; T Rosenberg; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-12       Impact factor: 3.117

4.  Dietary iodine intake and urinary iodine excretion in normal Korean adults.

Authors:  J Y Kim; S J Moon; K R Kim; C Y Sohn; J J Oh
Journal:  Yonsei Med J       Date:  1998-08       Impact factor: 2.759

5.  Aqueous flare in retinitis pigmentosa.

Authors:  M Küchle; N X Nguyen; P Martus; K Freissler; R Schalnus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-06       Impact factor: 3.117

6.  Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.

Authors:  Hakan Ozdemir; Murat Karacorlu; Serra Karacorlu
Journal:  Acta Ophthalmol Scand       Date:  2005-04

7.  Long-term treatment of retinitis pigmentosa with acetazolamide. A pilot study.

Authors:  N Orzalesi; C Pierrottet; A Porta; M Aschero
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-05       Impact factor: 3.117

8.  Day-to-day and within-day variation in urinary iodine excretion.

Authors:  L B Rasmussen; L Ovesen; E Christiansen
Journal:  Eur J Clin Nutr       Date:  1999-05       Impact factor: 4.016

9.  Non-retinovascular leakage in diabetic maculopathy.

Authors:  D Weinberger; S Fink-Cohen; D D Gaton; E Priel; Y Yassur
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

10.  A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.

Authors:  E L Berson; B Rosner; M A Sandberg; K C Hayes; B W Nicholson; C Weigel-DiFranco; W Willett
Journal:  Arch Ophthalmol       Date:  1993-06
View more
  2 in total

Review 1.  Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention.

Authors:  S Strong; G Liew; M Michaelides
Journal:  Br J Ophthalmol       Date:  2016-12-02       Impact factor: 4.638

2.  Effect of Lecithin-Bound Iodine Treatment on Inherited Retinal Degeneration in Mice.

Authors:  Hideo Kohno; Ryo Terauchi; Sumiko Watanabe; Kosuke Ichihara; Tomoyuki Watanabe; Euido Nishijima; Akira Watanabe; Tadashi Nakano
Journal:  Transl Vis Sci Technol       Date:  2021-11-01       Impact factor: 3.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.